| 000 | 01490 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515021907.0 | ||
| 264 | 0 | _c20061003 | |
| 008 | 200610s 0 0 eng d | ||
| 022 | _a0264-410X | ||
| 024 | 7 |
_a10.1016/j.vaccine.2006.03.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFirbas, Christa | |
| 245 | 0 | 0 |
_aImmunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects. _h[electronic resource] |
| 260 |
_bVaccine _cMay 2006 |
||
| 300 |
_a4343-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aHepatitis C _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-gamma _xbiosynthesis |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aSingle-Blind Method |
| 650 | 0 | 4 |
_aT-Lymphocytes _xmetabolism |
| 650 | 0 | 4 |
_aViral Vaccines _xadverse effects |
| 700 | 1 | _aJilma, Bernd | |
| 700 | 1 | _aTauber, Erich | |
| 700 | 1 | _aBuerger, Vera | |
| 700 | 1 | _aJelovcan, Sandra | |
| 700 | 1 | _aLingnau, Karen | |
| 700 | 1 | _aBuschle, Michael | |
| 700 | 1 | _aFrisch, Jürgen | |
| 700 | 1 | _aKlade, Christoph S | |
| 773 | 0 |
_tVaccine _gvol. 24 _gno. 20 _gp. 4343-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2006.03.009 _zAvailable from publisher's website |
| 999 |
_c16187741 _d16187741 |
||